$CBLI #Stocks #StockMarket #ClevelandBiolabs issued Q4 EPS on https://t.co/savSNTKlN1: Weak demand caused increase in losses for the Q4, company's loss per share grew to $-0.10 from $-0.04 where Sales fell by -24.62 % to $0.178 MM from $0.236 MM a year… https://t.co/0d23r9DwuH